Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37b416a8c0d2b0f1c3d6026d932027af |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-706 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2004-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9f898975286884178a8ae1a466619e9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e8187f58510bacd6a476a574e7db731 |
publicationDate |
2008-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2008145346-A1 |
titleOfInvention |
Methods And Compounds For Altering The Load Of Hepatitis Virus |
abstract |
The present invention relates to a method for altering the load of a Hepatitis virus present in an infected host organism. The method involves modulation of the complex formation of a heterogeneous nuclear ribonucleoprotein K (hnRNP K) and the regulatory region of a Hepatitis virus, enhancer II region. Additionally there are methods of identifying compounds that modulate complex formation, and the use of such compounds in diagnosis of a Hepatitis infection. The present invention also relates to a mutation in enhancer II region at position 1752 of the virus sequence which reduces the binding affinity of hnRNP K with the enhancer II region. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9034841-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200122397-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11517584-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102434346-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102434357-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-024762-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9127278-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8809293-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE48345-E http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9677076-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013003520-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210110900-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11590156-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103635576-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102554783-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220119522-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8642752-B2 |
priorityDate |
2003-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |